IMMULITE 2000 BR-MA L2KBR2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-04-04 for IMMULITE 2000 BR-MA L2KBR2 manufactured by Siemens Healthcare Diagnostics Products, Limited.

Event Text Entries

[71711755] The cause of the falsely elevated ca 15-3 results with kit lot 262 is unknown. Siemens is investigating the issue.
Patient Sequence No: 1, Text Type: N, H10


[71711756] The customer obtained falsely elevated ca 15-3 results on an immulite 2000 xpi instrument, while using kit lot 262. The initial result was reported to physician(s), who questioned the result. Repeat testing performed with the same sample and a new sample from the patient. The repeat results were also falsely elevated on the immulite 2000 xpi assay. The new sample from the patient was tested on an alternate platform at a different laboratory and the result was acceptable. It is unknown if the repeat results were reported to physician(s). There are no known reports of patient intervention due to the falsely elevated ca 15-3 result. There are no known reports of a delay in administering treatment or medical intervention to the patient due to the falsely elevated ca 15-3 result.
Patient Sequence No: 1, Text Type: D, B5


[76643982] The initial mdr 2432235-2017-00248 was filed on april 4th, 2017. Additional information (04/27/2017): a siemens headquarter support center (hsc) specialist reviewed the data provided by the customer and did not find any discrepancies with the assay adjustments and recoveries of quality control materials. The immulite 2000 br-ma (ca 15-3) instructions for use (ifu) states that ca 15-3 antigen levels in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods and reagent specificity. Results reported by the laboratory must include the identity of the assay used to measure ca 15-3 antigen levels. Values obtained with different assays cannot be used interchangeably. Before changing assays, the laboratory must confirm baseline values for patients being serially monitored. The cause of the bias between the methods cannot be determined. There were no other reports of discordant results being obtained with lot 262. Based on the available information, immulite 2000 br-ma (ca 15-3) lot 262 is performing as intended. The cause of the falsely elevated ca 15-3 results with kit lot 262 on the immulite 2000 xpi instrument is unknown. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2017-00248
MDR Report Key6457722
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-04-04
Date of Report2017-05-18
Date of Event2017-02-23
Date Mfgr Received2017-04-27
Date Added to Maude2017-04-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDEVYANI CHAUDHURI
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242637
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
Manufacturer StreetUK REGISTRATION #: 3002806944 GLYN RHONWY
Manufacturer CityLLANBERIS, GWYNEDD LL554EL
Manufacturer CountryUK
Manufacturer Postal CodeLL55 4EL
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMMULITE 2000 BR-MA
Generic NameIMMULITE 2000 BR-MA
Product CodeMOI
Date Received2017-04-04
Model NumberIMMULITE 2000 BR-MA
Catalog NumberL2KBR2
Lot Number262
Device Expiration Date2017-04-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
Manufacturer AddressGLYN RHONWY LLANBERIS, GWYNEDD LL554EL UK LL55 4EL


Patients

Patient NumberTreatmentOutcomeDate
10 2017-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.